Avalyn Pharma Inc. (AVLN)

Avalyn Pharma Inc. will go public soon, but the exact IPO date is still unknown.

Stock Price: Pending

IPO price not available yet

Avalyn Pharma Inc. Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Net Income	-85.2	-49.74
Depreciation & Amortization	-2.31	-2.55
Share-Based Compensation	3.27	2.47
Other Operating Activities	2.76	1.46
Operating Cash Flow	-81.48	-48.37
Capital Expenditures	-0.34	-0.1
Change in Investments	10.4	-131.34
Other Investing Activities	-	39.96
Investing Cash Flow	10.06	-91.47
Share Issuance / Repurchase	99.79	0.09
Financing Cash Flow	99.79	0.09
Net Cash Flow	28.36	-139.75
Free Cash Flow	-81.83	-48.46

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).